RSNA: Toshiba highlights MR technology

| | Health Imaging | Screening

Toshiba America Medical Systems (Booth #3438) is showcasing its Vantage Titan 1.5T MR series and MR tools as works in progress at RSNA 2012, in Chicago, Nov. 25-30.

The Vantage Titan 1.5T series includes the 8-, 16- and 32-channel MR systems and offers an upgrade path from the 8-channel to the 32-channel system.

Toshiba is sharing M-Power User Interface Upgrade, which automates certain steps with routine MR exams, and Pediatric Scan Apparatus, which positions the 16-element coils for pediatric head, neck and spine imaging. Both enhancements are works-in-progress.

The company also is introducing Spot Fluoro, a dose management tool for Infinix-i vascular X-ray systems. Spot Fluoro allows clinicians to view a region of anatomy using live fluoroscopy while viewing the Last Image Hold surrounding area.

 

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.